Presenting Companies at 2008 BIOCOM Investor Conference Announced
BIOCOM is proud to announce that applications from the following 49 public and private Southern California life science companies have been accepted for presentation slots at the third annual BIOCOM Investor Conference, to be held at the Hyatt Regency La Jolla, Oct. 27-28, 2008, with an opening reception on Sunday, Oct. 26. The 2008 BIOCOM Investor Conference will feature leading biotech and medical device companies from throughout Southern California giving company presentations to accredited investors over a two-day period, along with networking and one-on-one meeting opportunities.
Company and Web site (Stock symbol for public companies)
Adnavance
Adventrx Pharmaceuticals (ANX)
Alphatec Spine (ATEC)
Althea Technologies
Ambit Biosciences
Ambrx, Inc.
Amira Pharmaceuticals, Inc.
Amylin Pharmaceuticals (AMLN)
Anadys Pharmaceuticals, Inc. (ANDS)
Anaptys Biosciences
Arena Pharmaceuticals, Inc. (ARNA)
Avanir Pharmaceuticals (AVNR)
Avitacor LLC
Braincells Inc.
Cadence Pharmaceuticals (CADX)
CalciMedica
Cardium Therapeutics (CXM)
Cytori Therapeutics (CYTX)
DermTech
Digirad (DRAD)
EpiCept Corporation (EPCT)
Genoptix (GXDX)
Gen-Probe Incorporated (GPRO)
GenVault Corporation
Halozyme Therapeutics (HALO)
Histogen Inc.
Hollis-Eden Pharmaceuticals (HEPH)
Inovio Biomedical Corporation (INO)
Intrinsic LifeSciences
Invitrogen (IVGN)
Isis Pharmaceuticals, Inc. (ISIS)
Kaer BioTherapeutics
Metabasis Therapeutics, Inc. (MBRX)
Mpex Pharmaceuticals, Inc.
NexBio
Novocell
NventaBiopharmaceuticals Corporation (NVN.TO)
Orexigen Therapeutics, Inc. (OREX)
RegeneMed, Inc.
Regulus Therapeutics LLC
Spectrum Pharmaceuticals, Inc. (SPPI)
Theregen, Inc.
Tracon Pharmaceuticals, Inc.
Transdel Pharmaceuticals, Inc. (TDLP.OB)
Ultimate Labs
VentiRx Pharmaceuticals
Vical Inc. (VICL)
Vitreoretinal Technologies, Inc.
Volcano Corp. (VOLC)
Accepted presenting companies will be contacted by BIOCOM with further information about their presentation times at the upcoming conference.
There are a few remaining presentation slots and a waiting list for Southern California biotech and medical device companies interested in presenting to this audience of principal institutional and private equity investors. Please contact Valerie Sanderson at BIOCOM for information about additional slots.
For 2008, the BIOCOM Investor Conference has moved to a new location at the Hyatt Regency La Jolla, closer to the San Diego life science cluster at Torrey Pines.
The conference will start with an evening reception on Sunday, Oct. 26 and be followed by two days of company presentations, plenary sessions and an electronic reservation system for one-on-one meetings.
If you are an investor interested in attending the conference, please click here for information on registration.
Please click here to read a feature in the San Diego Union-Tribune about the 2007 BIOCOM Investor Conference.